Two Drug-Specific Projects In PCORI’s Initial Comparative Research Roster
This article was originally published in The Pink Sheet Daily
Executive Summary
The Patient-Centered Outcomes Research Institute announces the first 25 clinical comparative research projects it will fund, with two involving drug-specific comparisons: intravenous versus oral antibiotic therapy for serious bacterial infection and understanding long-term cognitive effects of different epilepsy medications in children.
You may also be interested in...
PCORI Grant Process Begins, But Challenge Of Involving Nontraditional Researchers Remains
The Patient-Centered Outcomes Research Institute approved its priorities and research agenda May 21, and revealed funding amounts for clinical comparative research the following day. But, as the board of governors’ discussion showed, one of PCORI’s biggest challenges remains how to bring in nontraditional researchers to help give its research a uniquely patient-centered focus.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.